Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ARIXTRA vs ASCIMINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ARIXTRA vs ASCIMINIB: Safety Overview

Metric ARIXTRA ASCIMINIB
Total FAERS Reports 298 2,330
Deaths Reported 80 269
Death Rate 26.8% 11.5%
Hospitalizations 151 426
Average Patient Age 60.4 yrs 61.2 yrs
% Female Patients N/A 50.5%
FDA Approval Date N/A Apr 18, 2024
Manufacturer N/A Novartis Pharmaceuticals Corporation
Route N/A ORAL
Marketing Status N/A Prescription